Eur Rev Med Pharmacol Sci 2024; 28 (8): 2986-2987
DOI: 10.26355/eurrev_202404_36010

Letter to the Editor on: Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion

S.H. Adeli, K. Jazi

Department of Internal Medicine, School of Medicine, Qom University of Medical Sciences, Qom, Iran. kimiajazi@gmail.com

Free PDF Download

To cite this article

S.H. Adeli, K. Jazi
Letter to the Editor on: Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion

Eur Rev Med Pharmacol Sci
Year: 2024
Vol. 28 - N. 8
Pages: 2986-2987
DOI: 10.26355/eurrev_202404_36010

Keywords Related articles:

  1. Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion
  2. Therapeutic effect of micropump intravenous infusion of ambroxol hydrochloride on respiratory distress syndrome in premature infants
  3. A randomized, double-blind, placebo-controlled study evaluating the efficacy of propolis and N-acetylcysteine in exacerbations of chronic obstructive pulmonary disease
  4. Phase I study of the pharmacokinetics and safety of single and multiple doses of intravenous N-acetylcysteine in healthy Chinese subjects
  5. Letter to editor, in response to letter entitled: Could monitoring normotensives delay progression to hypertension?